Williamson and Krebs (1) and Hall (2) have shown that acetoacetate and p-hydroxybutyrate inhibit the uptake and oxidation of glucose in the isolated, perfused rat heart. This effect is observed both in the presence (1) and in the absence (2) of insulin. Long-chain fatty acids also impair glucose utilization as shown by Shipp, Opie, and Challoner (3), Bowman (4) , and Minton and Raben (5) . A similar inhibition of glucose uptake by ketone bodies and fatty acids has been observed by using the isolated rat diaphragm. The mechanism of this effect has been studied by Newsholme and associates (6, 7) . They have shown that fatty acids reduce the sensitivity of glucose transport in muscle to the accelerating effect of insulin (7) and impair the intracellular phosphorylation of glucose by inhibition of the phosphofructokinase reaction (6) .
On the basis of these in vitro studies, Randle, Garland, Hales, and Newsholme (7) have recently advanced a general proposal that a rise in plasma fatty acids and ketone bodies may impair glucose utilization in the whole animal under certain conditions. On a clinical level, such an effect might relate to the diminished glucose utilization associated with diabetic ketoacidosis, and the glucose intolerance observed in Cushing's syndrome, acromegaly, and starvation. In these conditions, improvement in glucose tolerance coincides with a reduction in blood lipids and ketones (8).
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Randle and co-workers (7) , the infusion of ketone bodies into the normal, fasting dog induces hypoglycemia (9) . Recent studies suggest that this effect is due to a reduction in hepatic glucose output as a consequence of increased insulin secretion (10) (11) (12) .
In the present study, we have re-examined the effect of ketone body infusion in the intact dog with the view that either hyperglycemia or hypoglycemia might be induced, depending on the particular experimental conditions. According to the in vitro studies cited above, inhibition of glucose utilization by ketone bodies should be most readily demonstrable when the rate of glucose utilization in the peripheral tissues is elevated. A rapid utilization could be induced experimentally by a sustained infusion of glucose that raises the plasma concentration and stimulates release of endogenous insulin. Ketone bodies infused under these conditions had a hyperglycemic effect. On the other hand, when ketone bodies were infused into the normoglycemic dog, hypoglycemia was observed. The relationship of these observations to certain clinical syndromes is discussed.
Methods
Female mongrel dogs, weighing 9 to 16 kg, were housed in individual cages and fed Purina dog chow ad libitum for approximately 1 week before study. At least 7 days elapsed between experiments performed in the same dog. After 12 to 18 hours of fasting with free access to water, each dog was lightly anesthetized with an initial iv dose of sodium pentobarbital, 27 mg per kg, and maintained with supplemental doses as needed. Intermittent blood samples were withdrawn through a no. 18 gauge indwelling femoral arterial needle into heparinized syringes. All samples were promptly iced and the plasmas separated by centrifugation at 40 C.
Continuous monitoring of the glucose concentration of mixed venous blood was obtained with an autoanalyzer (13 Plasma ketone body concentrations were routinely determined in barium-zinc filtrates (17) as described by Chernick (18) . On occasion, the simplified micromethod of Pawan (19) was used to measure acetoacetate only. D (-) -,-Hydroxybutyrate was assayed enzymatically on the same filtrates with a partially purified enzyme preparation isolated from Rhodopseudomonas spheroides 4 as described by Williamson, Mellanby, and Krebs (20) .
Biopsy of quadratus femoris muscle of one side was performed just before the ketone body infusion, and the contralateral muscle was biopsied 60 minutes after the infusion was underway. A 4-to 5-g muscle segment was rapidly excised and frozen with a Wollenberger clamp (21) cooled in liquid nitrogen. Estimates of the glucose space and hexose phosphate concentrations were carried out enzymatically as described by Regen, Morgan, and Park (22) . Chloride space was determined by a microadaptation of the method of Sanderson (23) . II Results Hypoglycemia after ketone body infusion in the fasting dog. As noted in Figure 1 , the blood glucose of the normal fasting dog was constant throughout the period of observation (180 minutes) and was unaffected by the infusion of hypertonic saline of the same molarity as the ketone body infusions later employed. \Vhen sodium chloride was replaced by either acetoacetate or B-hydroxybutyrate, hypoglycemia promptly en- sued, in agreement with previous observations (9) (10) (11) . Acetoacetate was administered in buffered solution, and no significant change occurred in the blood pH. Figure 3 is a summary of four control glucose infusions and four with glucose and /8-hydroxybutyrate, whereas Figure 4 shows seven control and four with acetoacetate. The blood glucose concentrations are graphically presented as the mean + 1 SE. When glucose alone was infused, the adaptive fall in the blood sugar continued throughout the period of observation. XWhen the ketone infusion was begun during the equilibrium period, a gradual rise in the blood sugar concentration occurred. In the majority of animals, retardation in the glucose disappearance rate became manifest within 15 to 30 minutes after beginning the ketone body infusion as a progressive rise in blood glucose that continued throughout the period of observation. In the remainder, the ketone body infusion simply maintained the blood glucose at a constant level. glycemia with decreased insulin in the blood and pancreas by day 70. These authors suggested that ketone bodies first stimulate insulin secretion with gradual exhaustion of islet cells supervening (29) (30) (31) (32) (33) . Tidwell and Axelrod (34) also suggested that acetoacetate stimulates insulin release in the rat.
In fasting dogs given ,8-hydroxybutyrate, Neptune (9) observed a consistent drop in blood sugar. Madison and his associates ( 10-11), using dogs with chronic portacaval shunts, have provided further evidence for the prompt hypoglycemic effect of either acetoacetate or f8-hydroxybutyrate. They found an increased insulin content in pancreatic venous blood and attributed the hypoglycemia to a diminution of hepatic glucose output. Our findings in the normoglycemic dog ( Figure 1 and Table I ) are consistent with these studies. The improvement of glucose tolerance during ketone body-induced hypoglycemia (Figure 2 ) would be expected with higher levels of circulating insulin.
In the presence of sustained hyperglycemia, on the other hand, ketone bodies tend to raise the blood sugar concentration (Figures 3 and 4) . This effect is most simply interpreted as follows. Elevation of blood glucose is the optimal physiologic stimulus to the pancreatic fl-cells and raises insulin secretion to a level where no further response can be obtained from ketone bodies. The combination of hyperglycemia and elevated insulin arrests hepatic glucose output (12) and establishes a high rate of peripheral glucose uptake. Under these conditions, the inhibitory effect of ketone bodies on peripheral uptake becomes manifest by a rise in the blood glucose or an arrest of its normal tendency to fall. This interpretation is consistent with the demonstrated in vitro effects of ketone bodies on glucose utilization, but is obviously not established by the present data from the whole animal without estimates of glucose production and uptake rates.
Glucose uptake in the muscle biopsied in these experiments (Table II) was apparently limited by the membrane transport step, since no intracellular free glucose could be demonstrated (35) (36) . Studies in rats (37) have also failed to show intracellular free glucose in resting skeletal muscle even when marked hyperglycemia has been induced with presumably maximal release of endogenous insulin. Under these conditions, the important inhibitory effect of ketone bodies presumably is exerted at the transport level where they reduce the sensitivity to insulin (7) . With transport limiting the availability of substrate, an inhibition of glucose-or fructose-6-phosphate phosphorylation by the ketone bodies, unless extreme, would not be expected to cause any marked change in hexose phosphate concentrations.
Plasmas ketone body levels reached in these studies were well beyond the limits seen in diabetic ketoacidosis, and no attempt was made to determine the minimal effective concentration. The modest levels of plasma ketone bodies following an overnight fast may in themselves have some slight inhibitory effect upon peripheral glucose utilization. The release of such an inhibition could account for the progressive improvement of glucose utilization during the course of the control of glucose infusion (Figures 3 and 4) . A gradual increase in insulin production is another factor which may be involved.
The present experiments provide some support for the idea that ketone bodies may be diabetogenic under certain conditions. In particular, syndromes characterized by increased glucose production (analogous to the continuous infusion of glucose) and increased fat mobilization and catabolism should be considered. These metabolic alterations are commonly observed in Cushing's syndrome, certain forms of acromegaly, and in diabetic ketoacidosis. These states are also characterized by insulin insensitivity as would be expected from the effect of fatty acids and ketone bodies in in vitro systems (7) . The possibility is good that the elevated blood lipids also contribute to the glucose intolerance seen with fasting, as discussed by Randle and associates (7 
